Cure My Disease

Don't miss your cure!

 Log in / Sign up

HPV education showdown: video vs. Face-to-Face to boost vaccine uptake

NCT ID NCT07420556

Vaccine Sponsor: Emel GÜÇLÜ CİHAN Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 20, 2026 · Updated 2 times

Summary

This study tests whether teaching young women about HPV through a video or in person can increase their knowledge and willingness to get the HPV vaccine. About 117 women aged 18-24 who have not yet been vaccinated will take part. Researchers will compare the two teaching methods against a group that receives no education to see which works best.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

159 people

The number who actually took part.

Started

Dec 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 24 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participants must meet all of the following criteria to be included in the study: Aged 18-24 years, Residing in Afşin district, Kahramanmaraş province, Willing to voluntarily participate in the study, Literate and able to understand survey questions in Turkish, Have not previously received the HPV vaccine, Agree to be available throughout the study period (pre-test, post-education test, and 1-month follow-up test), Young women without physical or cognitive impairments or serious health problems that would prevent participation in the study. Exclusion Criteria: Participants will be excluded if they meet any of the following conditions: Under 18 or over 24 years of age, Have received the HPV vaccine or started the vaccine series, Have been diagnosed with HPV infection, Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test), Illiterate or unable to understand the study forms in Turkish, Withdraw from the study or indicate unwillingness to continue participation, Have serious hearing, vision, or cognitive impairments that would prevent meaningful engagement in the educational sessions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV vaccination acceptance/intention are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Health Education Infections human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV vaccination acceptance/intention Human papillomavirus (HPV) infection

Contacts and locations

Locations

  • Afşin Aile Sağlığı Merkezleri

    Kahramanmaraş, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.